Key statistics
As of last trade, Izotropic Corp (1R3:FRA) traded at 0.1195, 19.50% above the 52 week low of 0.10 set on Feb 06, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.1195 |
|---|---|
| High | 0.1195 |
| Low | 0.1195 |
| Bid | 0.1195 |
| Offer | 0.1535 |
| Previous close | 0.121 |
| Average volume | 571.43 |
|---|---|
| Shares outstanding | 69.22m |
| Free float | 65.49m |
| P/E (TTM) | -- |
| Market cap | 14.88m CAD |
| EPS (TTM) | -0.0436 CAD |
Data delayed at least 15 minutes, as of Feb 16 2026 07:12 GMT.
More ▼
Announcements
- Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System
- Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
- Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT
- AI in Breast Imaging: New BreastCT.com Article Examines IzoView’s Competitive Edge
- Izotropic’s IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose
- Izotropic Publishes New FAQ Page for Investors, Analysts, and Healthcare Decision-Makers
- Izotropic Secures Exclusive Rights to Patented Computer-Aided Diagnosis for Breast CT
- Izotropic’s AI Breakthrough Positions IzoView to Redefine Breast CT Imaging Standards
- BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic’s IzoView Device
- Izotropic Launches Podcast Episode #1: Beyond the Mammogram: Rethinking the Future of Breast Imaging
More ▼
